These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2701030)

  • 1. [Clinical evaluation of doxofylline sachets in a pediatric population].
    Bagnato G; Fodale P; Bottari M
    Riv Eur Sci Med Farmacol; 1989 Aug; 11(4):359-63. PubMed ID: 2701030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of reversible chronic airways obstruction with doxofylline compared with slow-release theophylline: a double-blind, randomized, multicentre trial.
    Melillo G; Balzano G; Jodice F; De Felice A; Campisi V; Capone M; Di Filippo A; Foddai G; Franzone JS; Grossi E
    Int J Clin Pharmacol Res; 1989; 9(6):397-405. PubMed ID: 2699466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial.
    Goldstein MF; Chervinsky P
    Med Sci Monit; 2002 Apr; 8(4):CR297-304. PubMed ID: 11951074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability of doxofylline in the maintenance therapy of pediatric patients with bronchial asthma.
    Bagnato GF
    Eur Rev Med Pharmacol Sci; 1999; 3(6):255-60. PubMed ID: 11261736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Systemic cardiorespiratory effects induced by doxofylline].
    Bagnato GF; Allegra A; De Leo A; Giacobbe MS; Mileto A; Cinquegrani M; Leotta G; Buemi AL; Spina E; Scibilia M
    Riv Eur Sci Med Farmacol; 1989 Feb; 11(1):29-35. PubMed ID: 2798988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heart rhythm changes in patients with chronic obstructive bronchopneumopathies: effects of different methylxanthine drugs].
    Cipri A; Pozzar F; Dini FL
    Minerva Cardioangiol; 1992; 40(1-2):31-9. PubMed ID: 1630668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of doxofylline compared to theophylline in asthma: A pooled analysis of functional and clinical outcomes from two multicentre, double-blind, randomized studies (DOROTHEO 1 and DOROTHEO 2).
    Calzetta L; Hanania NA; Dini FL; Goldstein MF; Fairweather WR; Howard WW; Cazzola M
    Pulm Pharmacol Ther; 2018 Dec; 53():20-26. PubMed ID: 30219705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral doxophylline in patients with chronic obstructive pulmonary disease.
    Villani F; De Maria P; Ronchi E; Galimberti M
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):107-11. PubMed ID: 9088999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical research with promolate (morphethylbutyne) as antitussive agent in some respiratory diseases].
    Visentin G; Di Vittorio G
    Clin Ter; 1979 Jul; 90(2):173-9. PubMed ID: 393449
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of patients with chronic airways obstruction: a controlled study with bamyphylline.
    Pulido E; Pupita F; Battistoni C
    Pharmatherapeutica; 1989; 5(6):416-22. PubMed ID: 2687897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of moderate chronic obstructive pulmonary disease (stable) with doxofylline compared with slow release theophylline--a multicentre trial.
    Santra CK
    J Indian Med Assoc; 2008 Dec; 106(12):791-2, 794. PubMed ID: 19370950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral and intravenous pharmacokinetic profiles of doxofylline in patients with chronic bronchitis.
    Bologna E; Laganà A; Terracino D; Bolignari P; Biffignandi P
    J Int Med Res; 1990; 18(4):282-8. PubMed ID: 2227075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the efficacy and safety of mepifylline in oral solution in children with mild and moderate asthmatic crises].
    Sienra Monge JJ; Prieto Ursúa L; Gerardo Sol Monterrey E; Estela del Río Navarro B; Paredes Novelo MC
    Allergol Immunopathol (Madr); 1994; 22(1):3-8. PubMed ID: 8030582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylxanthine drug therapy in chronic heart failure associated with hypoxaemia: double-blind placebo-controlled clinical trial of doxofylline versus theophylline and bamifylline.
    Dini FL; Pasini G; Cortellini G; Cani E; Bettini R; Garagnani A; Gobbi G; Greco A; Onorato G; Pasini P
    Int J Clin Pharmacol Res; 1993; 13(6):305-16. PubMed ID: 8088931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year.
    Zhou Y; Wang X; Zeng X; Qiu R; Xie J; Liu S; Zheng J; Zhong N; Ran P
    Respirology; 2006 Sep; 11(5):603-10. PubMed ID: 16916334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intravenously administered doxofylline and placebo for the treatment of severe acute airways obstruction.
    Dolcetti A; Osella D; De Filippis G; Carnuccio C; Grossi E
    J Int Med Res; 1988; 16(4):264-9. PubMed ID: 3169372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of the effect of a single oral dose of theophylline and etamiphyllin in children with asthma].
    Vázquez C; Labayru MT
    An Esp Pediatr; 1984 Nov; 21(8):739-46. PubMed ID: 6529027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
    Murali PM; Rajasekaran S; Paramesh P; Krishnarajasekar OR; Vasudevan S; Nalini K; Lakshmisubramanian S; Deivanayagam CN
    Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability and in vivo performance of a novel freon-free metered dose inhaler for a fixed combinational product of reproterol and disodium cromoglycate.
    Hermann R; Ruus P; Schneider E; de Mey C
    Arzneimittelforschung; 1998 Jun; 48(6):663-7. PubMed ID: 9689424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Doxofylline: pharmacologic profile and a review of clinical studies].
    Grossi E; Biffignandi P; Franzone JS
    Riv Eur Sci Med Farmacol; 1988 Nov; 10(5):415-30. PubMed ID: 3079129
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.